BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 35338146)

  • 1. Addressing a Pre-Clinical Pipeline Gap: Development of the Pediatric Acute Myeloid Leukemia Patient-Derived Xenograft Program at Texas Children's Hospital at Baylor College of Medicine.
    Stevens AM; Terrell M; Rashid R; Fisher KE; Marcogliese AN; Gaikwad A; Rao P; Vrana C; Krueger M; Loken M; Menssen AJ; Cook JA; Keogh N; Alozie M; Oviedo H; Gonzalez AK; Ilangovan T; Kim J; Sandhu S; Redell MS
    Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38397996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-Derived Xenograft Models for Leukemias.
    Brown FC; Carmichael CL
    Methods Mol Biol; 2024; 2806():31-40. PubMed ID: 38676794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive characterization of patient-derived xenograft models of pediatric leukemia.
    Rogojina A; Klesse LJ; Butler E; Kim J; Zhang H; Xiao X; Guo L; Zhou Q; Hartshorne T; Garcia D; Weldon K; Holland T; Bandyopadhyay A; Prado LP; Wang S; Yang DM; Langevan AM; Zou Y; Grimes AC; Assanasen C; Gidvani-Diaz V; Zheng S; Lai Z; Chen Y; Xie Y; Tomlinson GE; Skapek SX; Kurmasheva RT; Houghton PJ; Xu L
    iScience; 2023 Nov; 26(11):108171. PubMed ID: 37915590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapse-Fated Latent Diagnosis Subclones in Acute B Lineage Leukemia Are Drug Tolerant and Possess Distinct Metabolic Programs.
    Dobson SM; García-Prat L; Vanner RJ; Wintersinger J; Waanders E; Gu Z; McLeod J; Gan OI; Grandal I; Payne-Turner D; Edmonson MN; Ma X; Fan Y; Voisin V; Chan-Seng-Yue M; Xie SZ; Hosseini M; Abelson S; Gupta P; Rusch M; Shao Y; Olsen SR; Neale G; Chan SM; Bader G; Easton J; Guidos CJ; Danska JS; Zhang J; Minden MD; Morris Q; Mullighan CG; Dick JE
    Cancer Discov; 2020 Apr; 10(4):568-587. PubMed ID: 32086311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodeficient NBSGW mouse strain allows chemotherapy modeling in AML patient-derived xenografts.
    Dembitz V; Durko J; Campos J; James SC; Lawson H; Kranc KR; Gallipoli P
    Hemasphere; 2024 Jan; 8(1):e28. PubMed ID: 38434525
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative RNA-Seq Analysis Revealed Tissue-Specific Splicing Variations during the Generation of the PDX Model.
    Lee EJ; Noh SJ; Choi H; Kim MW; Kim SJ; Seo YA; Jeong JE; Shin I; Kim JS; Choi JK; Cho DY; Chang S
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal hematopoiesis of a novel dic(18;20) clone following allogeneic hematopoietic stem cell transplantation.
    Ito M; Fukushima N; Fujii T; Numata M; Morikawa S; Kawamura Y; Goto M; Kohno A; Imahashi N; Yasuda T; Sanada M; Ishikawa Y; Kiyoi H; Ozeki K
    Int J Hematol; 2024 Jan; 119(1):80-87. PubMed ID: 37980303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Leukemia Clearance After Adoptive Transfer of NK Cells Expressing the Bone Marrow Homing Receptor CXCR4
    Segerberg F; Lambert M; Sanz-Ortega L; Andersson A; Childs RW; Carlsten M
    Hemasphere; 2023 Nov; 7(11):e974. PubMed ID: 37936677
    [No Abstract]   [Full Text] [Related]  

  • 9. Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice.
    Gao J; Ren S; Choonoo G; Chen G; Frleta D; Zhong J; Gupta N; Sharma P; Oyejide A; Atwal GS; Macdonald L; Murphy A; Kuhnert F
    Dis Model Mech; 2023 Oct; 16(10):. PubMed ID: 37718909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration in molecular properties during establishment and passaging of endometrial carcinoma patient-derived xenografts.
    Imai T; Yoshida H; Machida Y; Kuramochi M; Ichikawa H; Kubo T; Takahashi M; Kato T
    Sci Rep; 2023 May; 13(1):8511. PubMed ID: 37231035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological characteristics associated with the engraftment of patient lymphoma cells in NOG mice.
    Sahashi S; Shimada K; Takagi Y; Aoki T; Kunou S; Sakamoto A; Murase A; Furukawa K; Kagaya Y; Yamaga Y; Takai M; Tokuyama K; Shimada S; Nakamura S; Kiyoi H
    Int J Hematol; 2023 Aug; 118(2):221-230. PubMed ID: 37129802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-derived xenograft models in cancer therapy: technologies and applications.
    Liu Y; Wu W; Cai C; Zhang H; Shen H; Han Y
    Signal Transduct Target Ther; 2023 Apr; 8(1):160. PubMed ID: 37045827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A never-ending FLT3 story.
    Kiyoi H
    Nagoya J Med Sci; 2023 Feb; 85(1):27-29. PubMed ID: 36923638
    [No Abstract]   [Full Text] [Related]  

  • 14. Chromatin mutations in pediatric high grade gliomas.
    Voon HPJ; Wong LH
    Front Oncol; 2022; 12():1104129. PubMed ID: 36686810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated multiomic approach for identification of novel immunotherapeutic targets in AML.
    Köhnke T; Liu X; Haubner S; Bücklein V; Hänel G; Krupka C; Solis-Mezarino V; Herzog F; Subklewe M
    Biomark Res; 2022 Jun; 10(1):43. PubMed ID: 35681175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clonal architecture between primary and immunodeficient mouse-engrafted acute myeloid leukemia cells.
    Kawashima N; Ishikawa Y; Kim JH; Ushijima Y; Akashi A; Yamaguchi Y; Hattori H; Nakashima M; Ikeno S; Kihara R; Nishiyama T; Morishita T; Watamoto K; Ozawa Y; Kitamura K; Kiyoi H
    Nat Commun; 2022 Mar; 13(1):1624. PubMed ID: 35338146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal architecture of secondary acute myeloid leukemia.
    Walter MJ; Shen D; Ding L; Shao J; Koboldt DC; Chen K; Larson DE; McLellan MD; Dooling D; Abbott R; Fulton R; Magrini V; Schmidt H; Kalicki-Veizer J; O'Laughlin M; Fan X; Grillot M; Witowski S; Heath S; Frater JL; Eades W; Tomasson M; Westervelt P; DiPersio JF; Link DC; Mardis ER; Ley TJ; Wilson RK; Graubert TA
    N Engl J Med; 2012 Mar; 366(12):1090-8. PubMed ID: 22417201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pursuing dynamics of minimal residual leukemic subclones in relapsed and refractory acute myeloid leukemia during conventional therapy.
    Kim D; Kim S; Song H; Gwak D; Min S; Byun JM; Koh Y; Hong J; Yoon SS; Yun H; Shin DY
    Cancer Med; 2024 Apr; 13(7):e7182. PubMed ID: 38591109
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.